Standard Life Aberdeen plc Has $720.23 Million Stake in UnitedHealth Group (UNH)

Standard Life Aberdeen plc trimmed its position in UnitedHealth Group (NYSE:UNH) by 4.4% during the fourth quarter, HoldingsChannel reports. The firm owned 3,262,434 shares of the healthcare conglomerate’s stock after selling 151,182 shares during the quarter. UnitedHealth Group accounts for approximately 1.4% of Standard Life Aberdeen plc’s investment portfolio, making the stock its 10th biggest holding. Standard Life Aberdeen plc’s holdings in UnitedHealth Group were worth $720,231,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Jennison Associates LLC lifted its holdings in shares of UnitedHealth Group by 10.2% in the fourth quarter. Jennison Associates LLC now owns 6,107,513 shares of the healthcare conglomerate’s stock valued at $1,346,462,000 after purchasing an additional 565,536 shares in the last quarter. Legal & General Group Plc lifted its holdings in shares of UnitedHealth Group by 1.3% in the third quarter. Legal & General Group Plc now owns 5,153,894 shares of the healthcare conglomerate’s stock valued at $1,009,355,000 after purchasing an additional 68,196 shares in the last quarter. UBS Asset Management Americas Inc. lifted its holdings in shares of UnitedHealth Group by 11.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 5,013,564 shares of the healthcare conglomerate’s stock valued at $1,105,290,000 after purchasing an additional 512,182 shares in the last quarter. American Century Companies Inc. lifted its holdings in shares of UnitedHealth Group by 1.4% in the fourth quarter. American Century Companies Inc. now owns 4,943,741 shares of the healthcare conglomerate’s stock valued at $1,089,897,000 after purchasing an additional 67,545 shares in the last quarter. Finally, Longview Partners Guernsey LTD lifted its holdings in shares of UnitedHealth Group by 0.4% in the fourth quarter. Longview Partners Guernsey LTD now owns 4,744,455 shares of the healthcare conglomerate’s stock valued at $1,045,963,000 after purchasing an additional 19,610 shares in the last quarter. Institutional investors own 86.79% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other UnitedHealth Group news, insider Larry C. Renfro sold 22,184 shares of the business’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the transaction, the insider now owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Kenneth Irwin Shine sold 198 shares of the business’s stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the sale, the director now owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. In the last three months, insiders have sold 77,015 shares of company stock worth $17,879,199. Company insiders own 0.89% of the company’s stock.

A number of analysts have recently commented on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price target on the stock in a report on Tuesday, April 3rd. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $280.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 8th. Barclays started coverage on UnitedHealth Group in a research report on Thursday, March 8th. They issued an “overweight” rating and a $265.00 target price on the stock. Finally, Argus lifted their target price on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research report on Thursday, January 18th. Two analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $244.06.

Shares of NYSE UNH opened at $223.96 on Monday. The company has a market cap of $216,717.81, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group has a twelve month low of $164.60 and a twelve month high of $250.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.11 earnings per share. analysts anticipate that UnitedHealth Group will post 12.51 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 29.79%.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3343042/standard-life-aberdeen-plc-has-720-23-million-stake-in-unitedhealth-group-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

FCB Financial  Set to Announce Quarterly Earnings on Tuesday
FCB Financial Set to Announce Quarterly Earnings on Tuesday
Restaurant Brands International  Set to Announce Quarterly Earnings on Tuesday
Restaurant Brands International Set to Announce Quarterly Earnings on Tuesday
Antero Midstream Partners  Set to Announce Quarterly Earnings on Wednesday
Antero Midstream Partners Set to Announce Quarterly Earnings on Wednesday
FirstEnergy  Releases Quarterly  Earnings Results, Misses Estimates By $0.01 EPS
FirstEnergy Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS
The Stars Group  Raised to Buy at Desjardins
The Stars Group Raised to Buy at Desjardins
Pilgrim’s Pride  Stock Rating Reaffirmed by Mizuho
Pilgrim’s Pride Stock Rating Reaffirmed by Mizuho


© 2006-2018 Ticker Report. Google+.